DiNuzzo Private Wealth’s Corcept Therapeutics CORT Stock Holding History

DiNuzzo Private Wealth’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$116	Hold	1	–	–	﹤0.01%	1311
2026 Q2	$87	Hold	1	–	–	﹤0.01%	1303
2026 Q1	$41	Sell	1 -16	-94%	-$598	﹤0.01%	1315
2025 Q4	$592	Hold	17	–	–	﹤0.01%	1031
2025 Q3	$1.19K	Hold	17	–	–	﹤0.01%	816
2025 Q2	$1.25K	Hold	17	–	–	﹤0.01%	790
2025 Q1	$1.94K	Hold	17	–	–	﹤0.01%	606
2024 Q4	$857	Sell	17 -1	-6%	-$52	﹤0.01%	898
2024 Q3	$834	Buy	18 +1	+6%	+$36	﹤0.01%	926
2024 Q2	$553	Buy	17 +1	+6%	+$27	﹤0.01%	1011
2024 Q1	$404	Sell	16 -1	-6%	-$24	﹤0.01%	1040
2023 Q4	$553	Buy	+17	New	+$467	﹤0.01%	940

Other funds holding CORT

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return

DiNuzzo Private Wealth's CORT Position: Q3 2026 in Review

DiNuzzo Private Wealth held its Corcept Therapeutics (CORT) position steady in Q3 2026 at 1 share worth $116. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

DiNuzzo Private Wealth first reported a position in CORT in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.94K in Q1 2025. 108 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

DiNuzzo Private Wealth held 1 share of Corcept Therapeutics worth $116 as of Q3 2026.
DiNuzzo Private Wealth left its Corcept Therapeutics share count unchanged in Q3 2026.
Corcept Therapeutics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #1311 holding.
DiNuzzo Private Wealth first reported a position in Corcept Therapeutics in Q4 2023 and has held it in 12 quarters since.
DiNuzzo Private Wealth's Corcept Therapeutics position peaked at $1.94K in Q1 2025.
108 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.